GlassScriptPhysician profile
Ankit M Patel
NPI 1548404411
$2,468.23
in general payments reported to CMS, 2019-2025
10 companies · $51.54 in 2025
The $51.54 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2021: $74.77 · 2022: $881 · 2023: $1,205 · 2024: $18.44 · 2025: $51.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $653 · Food and Beverage: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $653.14 |
| Food and Beverage | $621.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $1,994.67 | 2022-2023 | Intracept |
| Nevro Corp. | $140.28 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $97.72 | 2019 | |
| Stryker Corporation | $77.81 | 2023 | Optablate, Multigen 2 |
| Avanos Medical | $52.89 | 2021 | |
| Abbvie INC. | $30.31 | 2025 | |
| Emd Serono, INC. | $21.88 | 2021 | |
| Biogen, INC. | $21.23 | 2025 | Vumerity, Tysabri |
| Boston Scientific Corporation | $18.44 | 2024 | Intracept |
| Merz Pharmaceuticals, LLC | $13.00 | 2023 | Xeomin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankit Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.